John C. Jacobs, President, CEO at Harmony Biosciences Holdings, Inc. (HRMY), sold 50,000 shares at $43.63 ($2.2M) on 2022-06-13, disclosed to the SEC on 2022-06-14.
Open-market sale of $2.2M HRMY by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.63 | 9,803 | $428K | 19.4% |
| 2 | $43.63 | 9,803 | $428K | 19.4% |
| 3 | $44.53 | 15,197 | $677K | 30.6% |
| 4 | $44.53 | 15,197 | $677K | 30.6% |
| Total | $44.18 avg | 50,000 | $2.2M | 100% |
| Filing → |
| HRMY | SELL | 2022-03-18 | $680K | — | Filing → |
| HRMY | SELL | 2022-03-16 | $2.1M | — | Filing → |
| HRMY | SELL | 2022-01-05 | $2.6M | — | Filing → |